Even in both, in vitro as well as in vivo, a 25 μM resveratrol supplementation promoted the activation of p53 as well as its down-stream targets by modulation of Wnt/β-catenin, cyclin D1 and Bax/Bcl-2 signaling in CRC stem cells [43]. Here, TP53 is linked to colorectal carcinoma.